IMPACT BIOMEDICAL INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Impact Biomedical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2022 to Q1 2024.
  • Impact Biomedical Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$998K, a 17.6% decline year-over-year.
  • Impact Biomedical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$4.56M.
  • Impact Biomedical Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.41M, a 39.3% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4.56M -$998K -$149K -17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$4.41M -$1.26M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$1.18M +$1.06M +47.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1.12M -$322K -40.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-05
Q1 2023 -$849K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q3 2022 -$2.24M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$799K Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.